Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06011837 · ClinicalTrials.gov registry record · NA
Effects of Altered Auditory Feedback on Speech Fluency
A NA study, sponsored by Massachusetts Institute of Technology.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT06011837: Active NA study, sponsored by Massachusetts Institute of Technology.
NCT06011837 is a NA study that is active but no longer recruiting, run by Massachusetts Institute of Technology. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06011837, a NA study, is active but no longer recruiting, sponsored by Massachusetts Institute of Technology.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of the study is to use altered auditory vocal feedback to increase fluency in people who stutter and to examine changes in this effect over the course of a one month period occurring outside the laboratory setting.
Primary Outcome
Fluency change From Baseline - Week 4 Measured by Stuttering-Like Dysfluencies within voice recordings from participants
Interventions
- DEVICE Altered Auditory Feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-05-26 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
What the registry record for NCT06011837 still lists
NCT06011837 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Altered Auditory Feedback is the first listed.
NCT06011837 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06011837 about?
NCT06011837 is a clinical study titled "Effects of Altered Auditory Feedback on Speech Fluency". The purpose of the study is to use altered auditory vocal feedback to increase fluency in people who stutter and to examine changes in this effect over the course of a one month period occurring outside the laboratory setting.
What is the current status of trial NCT06011837?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-05-26. Estimated completion is 2026-06-01.
What interventions are being tested in trial NCT06011837?
The interventions under investigation include: Altered Auditory Feedback (DEVICE).
Who is sponsoring clinical trial NCT06011837?
This trial is sponsored by Massachusetts Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06011837's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI